RLMD
NASDAQ · Pharmaceuticals
Relmada Therapeutics Inc
$5.16
-0.21 (-3.91%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+624.2% upside
Low Target
$22.23
Average Target
$37.37
High Target
$43.38
Current Price
$5.16
Current
$5.16
$5.16
Target
$37.37
$37.37
$22.23
$37.37 avg
$43.38
Scenario Analysis
Bear Case
$22.23
330.8%
Low target
Base Case
$37.37
+624.2%
Avg target
Bull Case
$43.38
+740.7%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$8.00
-35.5% from high
52-Week Low
$0.55
+838.2% from low
Target vs 52W High
$37.37
+367.1% vs high
Peer Consensus — Pharmaceuticals